利用基因组学改善印度女性癌症预后:研究关键优先事项
本文为Lancet Oncol系列文章,指出乳腺癌、宫颈癌、卵巢癌和子宫癌合计占印度女性癌症70%以上,且乳腺癌和卵巢癌发病高峰年龄(45-50岁)比高收入国家(>60岁)早约十年。作者通过召集关键利益相关方研讨会,讨论印度癌症负担、基因组学研究与基础设施进展,并提出未来研究关键优先事项。
要点
- 印度女性乳腺癌和卵巢癌发病高峰约45-50岁,比高收入国家早约十年。
- 乳腺癌、宫颈癌、卵巢癌和子宫癌合计占印度女性癌症70%以上。
- 需开展针对印度人群的基因组研究以优化诊断、筛查、预防和治疗框架。
核心结论
- 印度女性癌症临床表现存在差异,提示生物学和遗传学差异,需开展针对印度人群的基因组研究以改善女性健康。
研究设计与样本
- 系列文章,基于召集关键利益相关方召开的研讨会,讨论印度癌症负担、基因组学研究与基础设施进展及未来研究优先事项。
主要发现
- 乳腺癌、宫颈癌、卵巢癌和子宫癌合计占印度女性癌症70%以上。
- 印度乳腺癌和卵巢癌发病高峰年龄为45-50岁,高收入国家为>60岁。
- 自2001年人类基因组测序以来,大规模并行测序等技术改变了对癌症遗传和环境驱动因素的理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70% of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45-50 years) than in high-income countries (age >60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India. Since the sequencing of the human genome in 2001, applications of advanced technologies, such as massively parallel sequencing, have transformed the understanding of the genetic and environmental drivers of cancer. How can advanced technologies be harnessed to provide health-care solutions at a scale and to a budget suitable for a country of 1·2 billion people? What research programmes are necessary to answer questions specific to India, and to build capacity for innovative solutions using these technologies? In order to answer these questions, we convened a workshop with key stakeholders to address these issues. In this Series paper, we highlight challenges in tackling the growing cancer burden in India, discuss ongoing genomics research and developments in infrastructure, and suggest key priorities for future research in cancer in India.
引用
- Sundar S, Khetrapal-Singh P, Frampton J, et al. Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research. Lancet Oncol. 2018. PMID: 29413464. doi:10.1016/S1470-2045(17)30726-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。